Procédés de traitement du retard mental, du syndrome de Down, du syndrome de l'X fragile et de l'autisme

• 收藏
• 分享

专利权人:

Seaside Therapeutics; Inc.

发明人:

申请号：

EP12184581.2

公开号：

EP2567696A1

申请日:

2007.11.21

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

Subjects having at least one condition selected from the group consisting of mental retardation, Down's syndrome, fragile X syndrome and autism are treated with a composition that includes gamma-am inobutyric acid agonists and/or MI muscarinic receptor antagonists. The gamma-am inobutyric acid agonist (GABA) can be a GABA(B) agonist, such as baclofen. GABA(B) agonists can be used in combination with Group I mGluR antagonists and MI muscarinic receptor antagonists in methods of treating humans.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/